A test of highly optimized tolerance reveals fragile cell-cycle mechanisms are molecular targets in clinical cancer trials
about
Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapyModeling and analysis of the molecular basis of pain in sensory neurons.Analysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems.Degeneracy as a substrate for respiratory regulation.Ensembles of signal transduction models using Pareto Optimal Ensemble Techniques (POETs)Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasisModeling and analysis of retinoic acid induced differentiation of uncommitted precursor cellsImpact of flow on ligand-mediated bacterial flocculation.Reduced order modeling and analysis of the human complement system.
P2860
Q28115758-54899B3F-B705-4FFC-A068-F450442143FDQ33502752-8ED4C2FB-39F0-41D6-A21D-E03C4EEDB216Q33529070-E91C686B-EC56-4CDB-9808-C3FD466FAFA3Q33912812-112CB325-7F7C-4D4C-ACE5-A98B02666715Q34495959-14529DB2-9F2C-4803-9D5F-6B1134BCC15CQ35907642-3599B534-7EE5-410C-A30C-2C9ACD56C8B2Q36938251-9635D518-903F-4E9C-B95F-0E8B600D829BQ42924108-772162DB-B6C9-4499-BE7D-FADAA04CB4E9Q47331810-CB6769BD-50D7-4FEC-8D31-6CF076F98A4B
P2860
A test of highly optimized tolerance reveals fragile cell-cycle mechanisms are molecular targets in clinical cancer trials
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A test of highly optimized tol ...... gets in clinical cancer trials
@ast
A test of highly optimized tol ...... gets in clinical cancer trials
@en
A test of highly optimized tol ...... ets in clinical cancer trials.
@nl
type
label
A test of highly optimized tol ...... gets in clinical cancer trials
@ast
A test of highly optimized tol ...... gets in clinical cancer trials
@en
A test of highly optimized tol ...... ets in clinical cancer trials.
@nl
prefLabel
A test of highly optimized tol ...... gets in clinical cancer trials
@ast
A test of highly optimized tol ...... gets in clinical cancer trials
@en
A test of highly optimized tol ...... ets in clinical cancer trials.
@nl
P2093
P2860
P1433
P1476
A test of highly optimized tol ...... gets in clinical cancer trials
@en
P2093
Deyan Luan
Jeffrey D Varner
Michael Zai
Saniya Salim
Satyaprakash Nayak
P2860
P356
10.1371/JOURNAL.PONE.0002016
P407
P577
2008-04-23T00:00:00Z